These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 16023232)

  • 1. The long-term survival benefit conferred by intermittent dobutamine infusions and oral amiodarone is greater in patients with idiopathic dilated cardiomyopathy than with ischemic heart disease.
    Tsagalou EP; Anastasiou-Nana MI; Terrovitis JV; Nanas SN; Alexopoulos GP; Kanakakis J; Nanas JN
    Int J Cardiol; 2006 Apr; 108(2):244-50. PubMed ID: 16023232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reverse left ventricular remodeling by intermittent dobutamine infusions and amiodarone in end-stage heart failure due to idiopathic dilated cardiomyopathy.
    Nanas JN; Tsagalou EP; Nanas SN; Terrovitis JV; Tsolakis EJ; Toumanidis S; Papazoglou PD; Alexopoulos GP; Kanakakis J; Anastasiou-Nana MI
    Int J Cardiol; 2006 Apr; 108(2):237-43. PubMed ID: 16183152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intermittent inotropic infusions combined with prophylactic oral amiodarone for patients with decompensated end-stage heart failure.
    Drakos SG; Kanakakis JV; Nanas S; Bonios M; Kaldara E; Katsaros F; Pantsios C; Nanas JN
    J Cardiovasc Pharmacol; 2009 Feb; 53(2):157-61. PubMed ID: 19188832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intermittent dobutamine treatment in patients with chronic refractory congestive heart failure: a randomized, double-blind, placebo-controlled study.
    Elis A; Bental T; Kimchi O; Ravid M; Lishner M
    Clin Pharmacol Ther; 1998 Jun; 63(6):682-5. PubMed ID: 9663183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term intermittent dobutamine infusion combined with oral amiodarone improves the survival of patients with severe congestive heart failure.
    Nanas JN; Kontoyannis DA; Alexopoulos GP; Anastasiou-Nana MI; Tsagalou EP; Stamatelopoulos SF; Moulopoulos SD
    Chest; 2001 Apr; 119(4):1173-8. PubMed ID: 11296186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amiodarone attenuates the proarrhythmic effects of dobutamine in patients with advanced congestive heart failure.
    Tsagalou EP; Gounopoulos P; Terrovitis JV; Drakos SG; Katsaros FT; Kaldara EE; Alexopoulos GP; Anastasiou-Nana MI
    Hellenic J Cardiol; 2009; 50(3):193-8. PubMed ID: 19465360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term intermittent dobutamine infusion, combined with oral amiodarone for end-stage heart failure: a randomized double-blind study.
    Nanas JN; Tsagalou EP; Kanakakis J; Nanas SN; Terrovitis JV; Moon T; Anastasiou-Nana MI
    Chest; 2004 Apr; 125(4):1198-204. PubMed ID: 15078725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in clinical profile and survival after heart transplantation according to prior heart disease.
    Agüero J; Almenar L; Martínez-Dolz L; Moro J; Izquierdo MT; Cano O; Salvador A
    Transplant Proc; 2007 Sep; 39(7):2350-2. PubMed ID: 17889185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Improvement of prognosis in idiopathic dilated cardiomyopathy: role of early diagnosis and optimized medical treatment. Study Group on Heart Muscle Diseases].
    Di Lenarda A; Hlede S; Sabbadini G; Davanzo M; Di Chiara C; Scherl G; Zanchi C; Sinagra G
    G Ital Cardiol; 1999 Dec; 29(12):1452-62. PubMed ID: 10687108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dobutamine effects on spontaneous variability of ventricular arrhythmias in patients with severe chronic heart failure: the Italian Multicenter Study.
    Puddu PE; Papalia U; Schiariti M; Usta C;
    Ital Heart J; 2004 Sep; 5(9):693-701. PubMed ID: 15568599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicentre, randomized trial on the benefit/risk profile of amiodarone, flecainide and propafenone in patients with cardiac disease and complex ventricular arrhythmias. Antiarrhythmic Drug Evaluation Group (A.D.E.G.).
    Eur Heart J; 1992 Sep; 13(9):1251-8. PubMed ID: 1396837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamics during chronic amiodarone administration in Japanese patients with idiopathic dilated cardiomyopathy and ventricular arrhythmia: a retrospective study.
    Suzuki T; Shiga T; Wakaumi M; Matsuda N; Ishizuka N; Kasanuki H
    J Cardiol; 2003 Apr; 41(4):169-73. PubMed ID: 12728537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intermittent infusions of dobutamine in the treatment of chronic cardiac failure in the terminal stage].
    Marcon JL; Bonijoly S; Favre E
    Ann Cardiol Angeiol (Paris); 1993 Nov; 42(9):495-502. PubMed ID: 8122866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of dobutamine-based and milrinone-based therapy for advanced decompensated congestive heart failure: Hemodynamic efficacy, clinical outcome, and economic impact.
    Yamani MH; Haji SA; Starling RC; Kelly L; Albert N; Knack DL; Young JB
    Am Heart J; 2001 Dec; 142(6):998-1002. PubMed ID: 11717603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amiodarone versus Implantable Defibrillator (AMIOVIRT): background, rationale, design, methods, results and implications.
    Wijetunga M; Strickberger SA;
    Card Electrophysiol Rev; 2003 Dec; 7(4):452-6. PubMed ID: 15071274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative analysis of short- and long-term outcomes after ventricular fibrillation out-of-hospital cardiac arrest in patients with ischemic and nonischemic heart disease.
    Bunch TJ; Kottke TE; Lopez-Jimenez F; Mahapatra S; Elesber AA; White RD
    Am J Cardiol; 2006 Oct; 98(7):857-60. PubMed ID: 16996862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of intermittent, long-term, concomitant dobutamine and levosimendan infusions in severe heart failure refractory to dobutamine alone.
    Nanas JN; Papazoglou P; Tsagalou EP; Ntalianis A; Tsolakis E; Terrovitis JV; Kanakakis J; Nanas SN; Alexopoulos GP; Anastasiou-Nana MI
    Am J Cardiol; 2005 Mar; 95(6):768-71. PubMed ID: 15757608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Syncope predicts the outcome of cardiomyopathy patients: analysis of the SCD-HeFT study.
    Olshansky B; Poole JE; Johnson G; Anderson J; Hellkamp AS; Packer D; Mark DB; Lee KL; Bardy GH;
    J Am Coll Cardiol; 2008 Apr; 51(13):1277-82. PubMed ID: 18371559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in management and outcome of ischemic and non-ischemic cardiomyopathy.
    Ng AC; Sindone AP; Wong HS; Freedman SB
    Int J Cardiol; 2008 Sep; 129(2):198-204. PubMed ID: 17706807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of oral nicorandil in patients with end-stage renal disease: a retrospective chart review after coronary angioplasty in Japanese patients receiving hemodialysis.
    Ishii H; Toriyama T; Aoyama T; Takahashi H; Yamada S; Kasuga H; Ichimiya S; Kanashiro M; Mitsuhashi H; Maruyama S; Matsuo S; Naruse K; Matsubara T; Murohara T
    Clin Ther; 2007 Jan; 29(1):110-22. PubMed ID: 17379051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.